SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trega Biosciences (TRGA), formerly HPIP

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E.J. Neitz Jr who wrote ()3/28/2000 12:14:00 PM
From: bob zagorin   of 152
 
SAN DIEGO and BOSTON, Mar 27, 2000 (BW HealthWire) --

BIO 2000--
BIOWIRE2K

The World's First Online Chemical Compound Marketplace Adds
Cross Indexing of Critical Research Information

ChemNavigator.com Inc. (www.chemnavigator.com), providing the world's first
online searchable database of commercially available drug-like chemical
compounds, has expanded its capabilities by providing cross-indexing of valuable
research information to structures in its iResearch(TM) System Library. This new
feature informs scientists when information from the newest version of Current
Drug's Investigational Drugs database -- IDdb3 -- is available on chemical
structures similar to those that have been returned in the scientist's search
query. This enables scientists to select and purchase compounds in a more
strategic way.

"The release of this new functionality marks a key milestone in the development
of the iResearch System," commented Scott Hutton, president of
ChemNavigator.com. "Our goal at ChemNavigator.com is to provide researchers with
tools and information to help them in the drug discovery process and by working
with Current Drugs we are moving aggressively toward that goal," he added.

This new functionality clearly differentiates ChemNavigator.com's iResearch
System from any other chemical listing or procurement service in the world
because it allows ChemNavigator.com members to view commercially available
drug-like compound libraries dynamically cross indexed, with validated,
information from patents, scientific literature and meetings, commercial sources
and direct company communications.

"The Fuzzy Chemical Similarity Join technology developed at ChemNavigator.com
enables scientists to see related sources of relevant chemical information on
the chemical libraries they design," commented Tad Hurst, Ph.D., vice president
and chief technical officer. "This new and powerful intelligence tool helps our
members design lead expansion libraries in a much more strategic manner.
Researchers who utilize ChemNavigator.com in their drug discovery research will
enjoy a wealth of information never before available in one format over the
Internet," continued Hurst.

When scientists use ChemNavigator.com's secure Internet-based iResearch(TM)
System to sketch, identify and purchase compounds, they will be presented with
hyperlinks indicating that information on their compounds is available from
IDdb3. They can easily access this information by linking to IDdb3 at
(www.iddb.com) and performing a search on the structure of interest. IDdb3
covers all aspects of world wide drug development, from first patent to eventual
launch or discontinuation, and offers a corporate-wide pharmaceutical
intelligence tool.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext